Ran GTPase-activating protein 1 (RanGAP1) is a critical regulator of nucleocytoplasmic transport and cell cycle progression. Its primary function is to hydrolyze GTP bound to the small GTPase Ran, converting it into its inactive GDP-bound form. This enzymatic activity plays a pivotal role in controlling the nucleocytoplasmic transport of macromolecules, including proteins and RNA, through the nuclear pore complex (NPC). By regulating the nucleocytoplasmic shuttling of various cargo molecules, RanGAP1 ensures proper cellular compartmentalization and facilitates essential cellular processes such as gene expression, signal transduction, and cell division.
The activation of RanGAP1 is tightly regulated and involves multiple steps. The key regulatory event in RanGAP1 activation is the formation of the RanGAP1/RanBP1 complex, which is facilitated by the interaction between RanGAP1 and the Ran-binding protein 1 (RanBP1). This complex formation enhances the catalytic activity of RanGAP1, leading to efficient hydrolysis of Ran-bound GTP. Additionally, RanGAP1 activation is influenced by the Ran guanine nucleotide exchange factor (RanGEF), also known as RCC1, which promotes the exchange of GDP for GTP on Ran, thereby regulating the availability of the active GTP-bound form of Ran. Furthermore, post-translational modifications, such as SUMOylation, phosphorylation, and ubiquitination, can modulate the activity and localization of RanGAP1, further fine-tuning its regulatory functions in nucleocytoplasmic transport and cell cycle progression. Overall, the precise regulation of RanGAP1 activity is essential for maintaining cellular homeostasis and coordinating fundamental cellular processes essential for cell viability and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
A Hsp90 inhibitor, potentially affecting the stability and function of Ran GAP1. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
Another Hsp90 inhibitor, could activate the stability and function of Ran GAP1. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibitor of CRM1/exportin 1, potentially activating nuclear export processes related to Ran GAP1. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
A NEDD8-activating enzyme inhibitor, might impact protein stability systems activating Ran GAP1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, could indirectly activating the degradation of Ran GAP1. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Another proteasome inhibitor, might activate Ran GAP1 stability. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, could indirectly activate Ran GAP1 through cellular growth and metabolic pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially activating signaling pathways involved in Ran GAP1 regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, could activate pathways related to Ran GAP1 activity. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
A cyclin-dependent kinase inhibitor, potentially activating cell cycle processes affecting Ran GAP1. | ||||||